Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. LIVN
LIVN logo

LIVN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy LivaNova PLC (LIVN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
65.810
1 Day change
-1.95%
52 Week Range
71.920
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

LivaNova PLC (LIVN) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown consistent revenue growth, its declining net income, EPS, and gross margin raise concerns about profitability. Additionally, the lack of strong trading signals and neutral sentiment from hedge funds and insiders suggest limited immediate upside. The stock is better suited for monitoring rather than immediate investment.

Technical Analysis

The technical indicators show a mixed picture. The MACD histogram is positive at 0.308, indicating bullish momentum, but it is contracting. RSI is neutral at 61.824, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are Pivot: 64.237, R1: 66.095, S1: 62.379, R2: 67.244, S2: 61.23. Overall, the stock is trading near resistance levels, suggesting limited immediate upside.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
2
Buy
9

Positive Catalysts

  • Analysts have raised price targets recently, citing strong Q4 performance and a solid 2026 outlook. The company has demonstrated double-digit revenue growth and strategic focus on core business innovation.

Neutral/Negative Catalysts

  • Net income, EPS, and gross margin have all declined significantly YoY in Q4 2025, raising concerns about profitability. There is no recent news or significant insider/hedge fund activity to act as a catalyst. Congress trading data is absent, and trading signals like AI Stock Picker and SwingMax are not present.

Financial Performance

In Q4 2025, revenue increased by 12.15% YoY to $360.92M. However, net income dropped by 44.70% YoY to $30.91M, and EPS fell by 44.12% YoY to $0.57. Gross margin also declined by 2.54% YoY to 66.43%. While revenue growth is strong, profitability metrics are concerning.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have raised price targets recently, with Barclays increasing to $73, Mizuho to $85, Baird to $83, Goldman Sachs to $73, and Stifel to $80. Ratings range from Neutral to Outperform, with a generally positive outlook for 2026. However, some analysts note that tailwinds from specific product cycles may be peaking.

Wall Street analysts forecast LIVN stock price to rise
8 Analyst Rating
Wall Street analysts forecast LIVN stock price to rise
6 Buy
2 Hold
0 Sell
Strong Buy
Current: 67.120
sliders
Low
64
Averages
72.5
High
85
Current: 67.120
sliders
Low
64
Averages
72.5
High
85
Barclays
Equal Weight
maintain
$67 -> $73
AI Analysis
2026-02-27
Reason
Barclays
Price Target
$67 -> $73
AI Analysis
2026-02-27
maintain
Equal Weight
Reason
Barclays raised the firm's price target on LivaNova to $73 from $67 and keeps an Equal Weight rating on the shares. The firm cites the company's Q4 beat for the target boost.
Mizuho
Outperform
upgrade
$72 -> $85
2026-02-26
Reason
Mizuho
Price Target
$72 -> $85
2026-02-26
upgrade
Outperform
Reason
Mizuho raised the firm's price target on LivaNova to $85 from $72 and keeps an Outperform rating on the shares. The firm views the company's 2026 outlook as solid.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for LIVN
Unlock Now

People Also Watch